Document Detail

Managing patients after myocardial infarction.
MedLine Citation:
PMID:  1968904     Owner:  NLM     Status:  MEDLINE    
Thrombolytic therapy clearly saves lives when administered in the first critical hours after acute MI. Consequently, most patients can now be treated initially at the community hospital level. Transfer to a tertiary center may be reserved for those who become symptomatic after thrombolysis, which, of course, is not a panacea. Reducing the risks of reinfarction and death remain major issues.
L S Cohen
Related Documents :
2688884 - Acute myocardial infarction: treatment with thrombolytic therapy.
7656544 - Massive pulmonary embolism. diagnostic and therapeutic strategies.
9447334 - The gusto trial and the open artery theory.
8315624 - Coronary care follow-up study: acute care required immediately following thrombolytic t...
8044934 - Ca(2+)-transporting atpase, phospholamban, and calsequestrin levels in nonfailing and f...
6883644 - Reduced space constant in slowly conducting regions of chronically infarcted canine myo...
Publication Detail:
Type:  Clinical Trial; Journal Article; Review    
Journal Detail:
Title:  Hospital practice (Office ed.)     Volume:  25     ISSN:  8750-2836     ISO Abbreviation:  Hosp. Pract. (Off. Ed.)     Publication Date:  1990 Mar 
Date Detail:
Created Date:  1990-04-13     Completed Date:  1990-04-13     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8404149     Medline TA:  Hosp Pract (Off Ed)     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  49-60     Citation Subset:  AIM; IM    
Yale University.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Antagonists / therapeutic use
Angioplasty, Transluminal, Percutaneous Coronary
Aspirin / therapeutic use
Calcium Channel Blockers / therapeutic use
Clinical Trials as Topic
Heart Function Tests
Myocardial Infarction / rehabilitation,  therapy*
Streptokinase / administration & dosage,  therapeutic use
Thrombolytic Therapy*
Tissue Plasminogen Activator / therapeutic use
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Calcium Channel Blockers; 50-78-2/Aspirin; EC 3.4.-/Streptokinase; EC Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Epidermal G1-chalone and transforming growth factor-beta are two different endogenous inhibitors of ...
Next Document:  Activated peripheral blood mononuclear cells detected by murine monoclonal antibodies to proliferati...